Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets

European Heart Journal

Volumn 34, Issue 15, 2013, Pages 1147-1156

  Kadota, Shin ^a,b,c   Minami, Itsunari ^a   Morone, Nobuhiro ^a   Heuser, John E ^a   Agladze, Konstantin ^a   Nakatsuji, Norio ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiac cell sheet; Drug screening; Human ES iPS cells; Reentrant arrhythmia; Spiral wave

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ALPHA ACTININ; CONNEXIN 43; LIDOCAINE; NIFEKALANT; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; TETRODOTOXIN; TROPONIN T;

ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL ORGANELLE; CONCENTRATION RESPONSE; DRUG RESPONSE; DRUG SCREENING; ELECTROSTIMULATION; EXTRACELLULAR SPACE; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; ION CURRENT; MYOFILAMENT; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QT PROLONGATION; RAT; REENTRY TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DESMOSOMES; ELECTRIC STIMULATION; HUMANS; MEMBRANE POTENTIALS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; SARCOMERES; SODIUM CHANNEL BLOCKERS; TISSUE ENGINEERING; VOLTAGE-SENSITIVE DYE IMAGING;

EID: 84876583275     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs418     Document Type: Article

References (32)

1. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004;22:1282-1289. (Pubitemid 39341201)
2. Gepstein L, Ding C, Rahmutula D, Wilson EE, Yankelson L, Caspi O, Gepstein A, Huber I, Olgin JE. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 2010;28:2151-2161.
3. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE, Laflamme MA. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012;489:322-325.
4. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A, Laugwitz K-L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010;363:1397-1409.
5. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471:225-229.
6. Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J, Dolmetsch RE. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011;471:230-234.
7. Jung CB, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, Dorn T, Ruppenthal S, Pfeiffer S, Goedel A, Dirschinger RJ, Seyfarth M, Lam JT, Sinnecker D, Gudermann T, Lipp P, Laugwitz KL. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 2012;4:180-191.
8. Ma D, Wei H, Lu J, Ho S, Zhang G, Sun X, Oh Y, Tan SH, Ng ML, Shim W, Wong P, Liew R. Generation of patient-specific induced pluripotent stem cellderived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. Advance Access published July 13, 2012, doi:10.1093/eurheartj/ehs226.
9. Ebert AD, Svendsen CN. Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov 2010;9:367-372.
10. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-39. (Pubitemid 36859038)
11. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-e41.
12. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park I-H, Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009;120: 1513-1523.
13. Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 2011;301:H2006-H2017.
14. Mehta A, Chung YY, Ng A, Iskandar F, Atan S,Wei H, Dusting G, SunW,Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virusfree induced pluripotent stem cells. Cardiovasc Res 2011;91:577-586.
15. Tung L, Zhang Y. Optical imaging of arrhythmias in tissue culture. J Electrocardiol 2006;39:S2-S6. (Pubitemid 44465948)
16. Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G, Beyar R, Balke CW, Schiller J, Gepstein L. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 2008;26:1961-1972.
17. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011;6:e18293.
18. Lee P, Klos M, Bollensdorff C, Hou L, Ewart P, Kamp TJ, Zhang J, Bizy A, Guerrero-Serna G, Kohl P, Jalife J, Herron TJ. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ Res 2012;110:1556-1563.
19. Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S, Kadota S, Morone N, Barve M, Asai Y, Tenkova-Heuser T, Heuser JE, Uesugi M, Aiba K, Nakatsuji N. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine-and xeno-free conditions. Cell Rep. Advance Access published October 23, 2012, doi: 10.1016/j.celrep.2012. 09.015.
20. Garcia-Frigola C, Shi Y, Evans SM. Expression of the hyperpolarization- activated cyclic nucleotide-gated cation channel HCN4 during mouse heart development. Gene Expr Patterns 2003;3:777-783. (Pubitemid 37451861)
21. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J. Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J 2008;95:4469-4480.
22. Kadota S, Kay MW, Magome N, Agladze K. Curvature-dependent excitation propagation in cultured cardiac tissue. Jetp Lett 2012;94:824-830.
23. Wymore RS, Gintant GA, Wymore RT, Dixon JE, McKinnon D, Cohen IS. Tissue and species distribution of mRNA for the IKr-like K+ channel, erg. Circ Res 1997;80:261-268. (Pubitemid 27056989)
24. Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi ME. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 2007;25:1136-1144. (Pubitemid 46684873)
25. Otsuji TG, Minami I, Kurose Y, Yamauchi K, Tada M, Nakatsuji N. Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res 2010;4:201-213.
26. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011;109:47-59.
27. Epstein JA, Franklin H. Epstein lecture. Cardiac development and implications for heart disease. N Engl J Med 2010;363:1638-1647.
28. Zhu WZ, Xie Y, Moyes KW, Gold JD, Askari B, Laflamme MA. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res 2010;107:776-786.
29. Macia E, Boyden PA. Stem cell therapy is proarrhythmic. Circulation 2009;119: 1814-1823.
30. Ly HQ, Nattel S. Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation 2009;119:1824-1831.
31. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-1022. (Pubitemid 38269278)
32. Yamazaki M, Honjo H, Nakagawa H, Ishiguro YS, Okuno Y, Amino M, Sakuma I, Kamiya K, Kodama I. Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant. Am J Physiol Heart Circ Physiol 2007;292:H539-H548. (Pubitemid 46105218)